U.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose.
On Thursday, Oct. 14, 2021, advisers to the Food and Drug Administration evaluated the evidence that Moderna boosters should be offered, too -- and on Friday, they’ll tackle the same question for those who got Johnson & Johnson’s vaccine.
FILE - This Wednesday, Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. On Thursday, Oct. 14, 2021, advisers to the Food and Drug Administration evaluated the evidence that Moderna boosters should be offered, too -- and on Friday, they’ll tackle the same question for those who got Johnson & Johnson’s vaccine.
Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand. Thursday, advisers to the Food and Drug Administration evaluated the evidence that Moderna boosters should be offered, too -- and on Friday, they’ll tackle the same question for those who got Johnson & Johnson’s vaccine.
U.S. officials stress that the priority is to get shots to the 66 million unvaccinated Americans who are eligible for immunization -- those most at risk as the extra-contagious delta variant of the coronavirus has burned across the country. “It’s important to remember that the vaccines still provide strong protection against serious outcomes” such as hospitalization and death from COVID-19, said FDA vaccine chief Dr. Peter Marks.But Marks said it’s also become clear there is some waning of protection against milder infections with all three of the coronavirus vaccines used in the U.S.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Moderna asks for booster clearance ahead of FDA panel meetingsAn FDA advisory committee will meet Thursday and Friday to discuss booster doses for the Moderna and Johnson & Johnson Covid vaccines.
Baca lebih lajut »
FDA Neutral on Moderna Bid for Booster Ahead of Decisive MeetingThe FDA is keeping its cards close to the vest when it comes to the potential approval of a booster dose of Moderna’s COVID-19 vaccine.
Baca lebih lajut »
U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersScientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot's first two doses has remained strong.
Baca lebih lajut »
Moderna urges FDA to authorize a half-size booster dose of its Covid-19 vaccine for some adultsModerna is urging the FDA to authorize a half-size booster of its Covid-19 vaccine, according to a briefing document posted Tuesday, ahead of a key meeting of the agency's vaccine advisers.
Baca lebih lajut »
Next on FDA's agenda: Booster shots of the Moderna and J&J vaccinesMillions of Americans who got the Moderna or Johnson & Johnson COVID-19 vaccines will soon learn when they'll be eligible for booster shots.
Baca lebih lajut »